echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Diagnostic Test > Using improved MRS to identify glioma IDH mutation in the body

    Using improved MRS to identify glioma IDH mutation in the body

    • Last Update: 2020-06-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Ref: Branzoli F,et al.Neuro Oncol.
     2018 Jun 18;20 (7): 907-916doi: 10.1093/neuonc/nox214.)about 70-90% of grade II, Class III gliomas and glioblastomas (GBM) can have isiscite dehydrogenase (IDH) mutations, which are characterized by biological characteristics different from THOSE wild gliomasAt present, IDH has been recognized as the main marker for the prognosis of gliomahow to detect the state of the idh mutation in the glioma of the body brain by noninvasive methods has not been reportedFrancesca Branzoli, of the Institute of Neuroimaging at the Cerveau de la Moelle Institute in Paris, Francesca Branzoli, and others used magnetic resonance spectrum (MRS) imaging to detect metabolites 2-hydroxydoxic acid (2HG) to determine the status of the IDH mutation in patients with glioma, published in the June 2018 issue of NeuroOncolthis prospective study included 24 patients with low-grade gliomasMrS data was obtained on 3T MRI devices using 2 MRS imaging methods, improved MRS detection was performed through the Mescher-Garwood Resolution Spectrometry (MEGA-PRESS) sequence, and HG2 was detected using the espresso-optimized PRESS sequence of .6mLthen, automated immunohistochemical analysis is combined with Sanger sequencing to determine the idh mutation stateThe 2HG level of tissue samples was then measured by gas chromatography-mass spectrometry and compared with the MRS test resultsIt was found that the specificity and sensitivity of the improved MRS sequence in detecting 2HG reached 100%The 2HG level assessed by this technique is consistent with the 2HG level measured from tissue samples The performance of 2HG is lower to optimize the PRESS sequence detection the authors believe that improved MRS is a reliable means of non-invasive detection of IDH mutations, showing high sensitivity and specificity to 2HG detection Integrating improved MRS into clinical practice is beneficial to noninvasive diagnosis, prognosis and treatment plan for glioma (First Hospital of Fuzhou Serena compiled, Professor Wang Zhiqiu , of Huashan Hospital affiliated with Fudan University, editor-in-chief of "Outside The God Information" and Of Fudan University affiliated Huashan Hospital, Professor Chen Jicheng ) related links
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.